Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins
Authors:
- 1 December 2001
- journal article
- review article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 23 (4) , 447-457
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathiesJournal of the Neurological Sciences, 1996
- Intra-articular Administration of Polyclonal Immunoglobulin G in Rheumatoid Arthritis: A double-blind, placebo-controlled pilot studyScandinavian Journal of Rheumatology, 1996
- Spontaneous Recovery from the Guillain-Barré Syndrome Is Associated with Anti-idiotypic Antibodies Recognizing a Cross-Reactive Idiotype on Anti-neuroblastoma Cell Line AntibodiesClinical Immunology and Immunopathology, 1993
- Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunityJournal of Autoimmunity, 1992
- Composition of immune deposits present in glomeruli of NZB/W F1 miceClinical Immunology and Immunopathology, 1991
- Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globulinJournal of Clinical Immunology, 1991
- Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulinJournal of Molecular Medicine, 1989
- Identification by HLA Typing of Intrauterine-Derived Maternal T Cells in Four Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1982
- Antinuclear Antibody Staining Only Centrioles in a Patient with SclerodermaNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981